Synonyms:
Status: Phase 2
Entry Type: Small molecule
Molecule Category: UNKNOWN
UNII: QKT1LC4J1P

Structure

InChI Key LFQCJSBXBZRMTN-OAQYLSRUSA-N
Smile CC[C@@]1(O)CC(=O)OCc2c1cc1n(c2=O)Cc2cc3cc(F)c(F)cc3nc2-1
InChI
InChI=1S/C21H16F2N2O4/c1-2-21(28)7-18(26)29-9-12-13(21)5-17-19-11(8-25(17)20(12)27)3-10-4-14(22)15(23)6-16(10)24-19/h3-6,28H,2,7-9H2,1H3/t21-/m1/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C21H16F2N2O4
Molecular Weight 398.37
AlogP 2.75
Hydrogen Bond Acceptor 6.0
Hydrogen Bond Donor 1.0
Number of Rotational Bond 1.0
Polar Surface Area 81.42
Molecular species NEUTRAL
Aromatic Rings 3.0
Heavy Atoms 29.0

Pharmacology

Action Mechanism of Action Reference
INHIBITOR DNA topoisomerase I inhibitor PubMed PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Small Cell Lung Carcinoma 2 D055752 ClinicalTrials

Related Entries

Scaffolds

Cross References

Resources Reference
ChEBI 144046
ChEMBL CHEMBL306280
DrugBank DB16138
FDA SRS QKT1LC4J1P
PubChem 219023
SureChEMBL SCHEMBL1650167